Xiaocong Pang

1.3k total citations
45 papers, 873 citations indexed

About

Xiaocong Pang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaocong Pang has authored 45 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Xiaocong Pang's work include Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (5 papers). Xiaocong Pang is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (5 papers). Xiaocong Pang collaborates with scholars based in China, Macao and United States. Xiaocong Pang's co-authors include Yimin Cui, Guanhua Du, Shiliang Wu, Jinhua Wang, Bin‐Zhi Qian, Xiaodan Zhang, Xiangjin Zheng, Kan Gong, Yi Zhun Zhu and Jinyi Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and Frontiers in Immunology.

In The Last Decade

Xiaocong Pang

39 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaocong Pang China 16 506 230 168 153 116 45 873
Ying‐Yu Ma China 20 619 1.2× 299 1.3× 204 1.2× 160 1.0× 166 1.4× 54 1.0k
Pingsheng Chen China 18 707 1.4× 373 1.6× 104 0.6× 120 0.8× 94 0.8× 48 1.2k
Jianfeng Cui China 16 331 0.7× 166 0.7× 173 1.0× 149 1.0× 88 0.8× 46 736
Wanfu Xu China 21 706 1.4× 386 1.7× 263 1.6× 242 1.6× 245 2.1× 60 1.3k
Bo Tang China 18 522 1.0× 168 0.7× 451 2.7× 111 0.7× 116 1.0× 58 1.1k

Countries citing papers authored by Xiaocong Pang

Since Specialization
Citations

This map shows the geographic impact of Xiaocong Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaocong Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaocong Pang more than expected).

Fields of papers citing papers by Xiaocong Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaocong Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaocong Pang. The network helps show where Xiaocong Pang may publish in the future.

Co-authorship network of co-authors of Xiaocong Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaocong Pang. A scholar is included among the top collaborators of Xiaocong Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaocong Pang. Xiaocong Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhuo, et al.. (2025). The Safety of Cadonilimab: A Systematic Review and Single‐Arm Meta‐Analysis. Cancer Medicine. 14(17). e71210–e71210. 1 indexed citations
2.
Zhang, Yushi, Lu Zhang, Liyu Sun, et al.. (2025). Engineering NK cell membrane-camouflaged copper-BODIPY nanoassembly to synergize dual-phototherapy and cuproptosis for enhanced antitumor immunity. Chemical Engineering Journal. 526. 170867–170867.
3.
Zhang, Junling, Qingqing Xiong, Xin Wang, et al.. (2024). Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage. Advanced Science. 12(1). e2400367–e2400367. 6 indexed citations
4.
Duan, Zhenya, et al.. (2023). Development of a Novel Multi-Phase Flow Reactor and Optimization of Mixing Effect Based on a Liquid-Liquid System. Theoretical Foundations of Chemical Engineering. 57(S1). S36–S50.
5.
Gu, Yanlun, He Xu, Zhiwei Qiu, et al.. (2023). The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials. Pharmacological Research. 189. 106694–106694. 36 indexed citations
6.
Gong, Mingli, et al.. (2023). Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis. Frontiers in Immunology. 14. 1197275–1197275. 20 indexed citations
7.
Zhang, Zhuo, Zhiqi Wang, Ran Xie, et al.. (2022). The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer. Frontiers in Immunology. 13. 1033967–1033967. 3 indexed citations
8.
Zhao, Jian, Hui Feng, Tingting Wang, et al.. (2021). The safety and efficacy of a novel method for treatment of HSIL. Archives of Gynecology and Obstetrics. 304(5). 1291–1298. 5 indexed citations
9.
Su, Xian, Xiaocong Pang, Xin Zeng, et al.. (2021). Analysis of Suspension of Clinical Trials for Drug Registration in China. Frontiers in Pharmacology. 11. 598574–598574. 7 indexed citations
10.
Pang, Xiaocong, Liu C, & Baogan Peng. (2020). Anterior Cervical Surgery for the Treatment of Cervicogenic Headache Caused by Cervical Spondylosis. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Pang, Xiaocong, Ying Zhao, Jinhua Wang, et al.. (2019). Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer. Oxidative Medicine and Cellular Longevity. 2019. 1–21. 9 indexed citations
12.
Pang, Xiaocong, Kan Gong, Xiaodan Zhang, et al.. (2019). Osteopontin as a multifaceted driver of bone metastasis and drug resistance. Pharmacological Research. 144. 235–244. 145 indexed citations
13.
Yang, Feng‐Chun, et al.. (2018). Lycium barbarum polysaccharide prevents cisplatin-induced MLTC-1 cell apoptosis and autophagy via regulating endoplasmic reticulum stress pathway. SHILAP Revista de lepidopterología.
14.
Zheng, Xiangjin, Li Wan, Liwen Ren, et al.. (2018). The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy. Pharmacology & Therapeutics. 195. 85–99. 97 indexed citations
15.
Liu, Jinyi, Xiangjin Zheng, Xiaocong Pang, et al.. (2018). Ganglioside GD3 synthase (GD3S), a novel cancer drug target. Acta Pharmaceutica Sinica B. 8(5). 713–720. 37 indexed citations
16.
Pang, Xiaocong, et al.. (2018). Network pharmacology-based study of the active constituents of Chinese medicinal formulae for antitumor mechanism. World Journal of Traditional Chinese Medicine. 4(2). 43–43. 2 indexed citations
17.
Pang, Xiaocong, et al.. (2017). Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Pang, Xiaocong, Ying Zhao, Jinhua Wang, et al.. (2017). The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer’s Disease. BioMed Research International. 2017. 1–16. 26 indexed citations
19.
Wang, Jinhua, Wan Li, Ying Zhao, et al.. (2017). Members of FOX family could be drug targets of cancers. Pharmacology & Therapeutics. 181. 183–196. 50 indexed citations
20.
Gao, Li, Chao Li, Ranyao Yang, et al.. (2015). Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson's disease: A microarray study. Pharmacology Biochemistry and Behavior. 133. 155–163. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying‐Yu Ma Breakdown of academic impact, for papers by Pingsheng Chen Breakdown of academic impact, for papers by Jianfeng Cui Breakdown of academic impact, for papers by Wanfu Xu Breakdown of academic impact, for papers by Bo Tang
Rankless by CCL
2026